Display options
Cite
Permikin Z, Popov A, Verzhbitskaya T, et al. Lineage switch to acute myeloid leukemia during induction chemotherapy for early T-cell precursor acute lymphoblastic leukemia with the translocation t(6;11)(q27;q23)/KMT2A-AFDN: A case report. Leuk Res. 2021;112:106758doi: 10.1016/j.leukres.2021.106758.
Permikin, Z., Popov, A., Verzhbitskaya, T., Riger, T., Plekhanova, O., Makarova, O., Froňková, E., Trka, J., Meyer, C., Marschalek, R., Tsaur, G., & Fechina, L. (2021). Lineage switch to acute myeloid leukemia during induction chemotherapy for early T-cell precursor acute lymphoblastic leukemia with the translocation t(6;11)(q27;q23)/KMT2A-AFDN: A case report. Leukemia research, 112106758. https://doi.org/10.1016/j.leukres.2021.106758
Permikin, Zhan, et al. "Lineage switch to acute myeloid leukemia during induction chemotherapy for early T-cell precursor acute lymphoblastic leukemia with the translocation t(6;11)(q27;q23)/KMT2A-AFDN: A case report." Leukemia research vol. 112 (2021): 106758. doi: https://doi.org/10.1016/j.leukres.2021.106758
Permikin Z, Popov A, Verzhbitskaya T, Riger T, Plekhanova O, Makarova O, Froňková E, Trka J, Meyer C, Marschalek R, Tsaur G, Fechina L. Lineage switch to acute myeloid leukemia during induction chemotherapy for early T-cell precursor acute lymphoblastic leukemia with the translocation t(6;11)(q27;q23)/KMT2A-AFDN: A case report. Leuk Res. 2021 Nov 25;112:106758. doi: 10.1016/j.leukres.2021.106758. Epub 2021 Nov 25. PMID: 34864370.
Copy Download .nbib Format: NLM
Share it on

Leuk Res. 2021 Nov 25;112:106758. doi: 10.1016/j.leukres.2021.106758. Epub 2021 Nov 25.

Lineage switch to acute myeloid leukemia during induction chemotherapy for early T-cell precursor acute lymphoblastic leukemia with the translocation t(6;11)(q27;q23)/KMT2A-AFDN: A case report.

Leukemia research

Zhan Permikin, Alexander Popov, Tatiana Verzhbitskaya, Tatiana Riger, Olga Plekhanova, Olga Makarova, Eva Froňková, Jan Trka, Claus Meyer, Rolf Marschalek, Grigory Tsaur, Larisa Fechina

Affiliations

  1. Regional Children's Hospital, Ekaterinburg, Russian Federation; Ural State Medical University, Ekaterinburg, Russian Federation.
  2. National Medical Research Center of Pediatric Hematology, Oncology and Immunology, 1 Samory Mashela St., 117998, Moscow, Russia. Electronic address: [email protected].
  3. Regional Children's Hospital, Ekaterinburg, Russian Federation; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation.
  4. Regional Children's Hospital, Ekaterinburg, Russian Federation.
  5. Charles University, CLIP, Prague, Czech Republic; Motol University Hospital, Prague, Czech Republic.
  6. Institute of Pharmaceutical Biology/DCAL, Goethe-University of Frankfurt, Frankfurt am Main, Germany.
  7. Regional Children's Hospital, Ekaterinburg, Russian Federation; Ural State Medical University, Ekaterinburg, Russian Federation; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation.

PMID: 34864370 DOI: 10.1016/j.leukres.2021.106758

[No abstract available.]

Keywords: Acute myeloid leukemia; Early T-cell precursor leukemia; KMT2A-AFDN; Lineage switch

Publication Types